作者: Laura Ottini , Mario Falchetti , Gabriella Nesi
DOI: 10.1007/978-1-61779-358-5_7
关键词: Oncology 、 Prognostic variable 、 Internal medicine 、 Cancer 、 Poor prognosis 、 Relative resistance 、 Gene 、 Incidence (epidemiology) 、 Radiation therapy 、 Medicine 、 Chemotherapy
摘要: Although the incidence and mortality of Gastric Cancer (GC) have fallen over past 70 years, GC continues to be second leading cause cancer death fourth most common malignant neoplasia across world. still represents a major clinical challenge because it has poor prognosis limited treatment options due its relative resistance radiotherapy chemotherapy. At present, tumour stage provides prognostic variables used in management patients. However, with similar morphology may display different biological aggressiveness, response therapy.